Navigation Links
Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress 'A Design for a Bundled End Stage Renal Disease Prospective Payment System'
Date:2/21/2008

WASHINGTON, Feb. 21 /PRNewswire-USNewswire/ -- The following is a statement by Robert D. Foreman, President of The Kidney Care Council:

"The Kidney Care Council (KCC) supports the findings of the Centers for Medicare & Medicaid Services (CMS) which in a long awaited report yesterday made clear that the time for a modernized and fully bundled case-mix adjusted prospective payment system for dialysis services is upon us. We could not agree more.

"For too long, the dialysis payment system has languished far behind other prospective payment systems in Medicare and has suffered from a lack of an annual updating mechanism. We are pleased to see the report recognizes the under-funding of the composite payment rate which cites the average cost of a treatment was $162.00 versus a reimbursement of $143.20.

"The report leaves open some details about the bundle's basic design features that need to be resolved for a new payment system to be fully successful. Specifically, the success of the revised payment mechanism will depend largely on the establishment of an appropriate rate at the outset as well as the design of an annual update mechanism. However, we are pleased by the progress and insights in the report and are eager to work collaboratively with CMS and with Congress this year.

"The KCC also applauds the work of those in the Government Accountability Office, the Medicare Payment Advisory Commission, and in Congress in advancing the payment modernization cause. The CMS report is a fitting culmination to more than a decade of thoughtful work by CMS and leading researchers on how best to reimburse care for Medicare's most vulnerable beneficiaries. Congress now has before it a concrete and detailed proposal. Now, let the hard work of making it happen begin.

"The KCC has endorsed payment reform and has taken a collaborative approach to positive change for the dialysis payment system, working closely with Congress, CMS, and patient and stakeholder groups to secure a system that maximizes taxpayer value and promotes high quality care. We believe the expanded prospective payment envisioned in this report will provide stable, predictable reimbursement that will support continued improvement in clinical patient outcomes. To these ends, the KCC will continue working with Members of Congress to enact these long overdue changes this year.

The Kidney Care Council (KCC) is a nonprofit Washington-based health care trade association of eleven renal care companies that collectively provide End-Stage Renal Disease (ESRD) services to nearly 80 percent of the dialysis patients in the United States. The membership includes large, small, nonprofit and for-profit provider companies. The KCC's mission is to improve patient care through demonstrable improvements in patient outcomes, patient safety, and quality of life measures. The KCC is dedicated to improving quality as well as promoting education so that newly diagnosed patients fully understand this disease and how to slow its progression and reduce complications.


'/>"/>
SOURCE Kidney Care Council (KCC)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
2. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
3. AHIP Statement on New York Attorney Generals Announcement
4. NCPA Statement on Economic Stimulus Package
5. Blue Cross of California Statement
6. Statement by James P. Firman, Chair Leadership Council of Aging Organizations (LCAO) on the Presidents FY2009 Budget Proposal
7. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
8. NCPA Statement in Response to President Bushs FY 2009 Budget Proposal
9. NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse
10. Statement of the American Diabetes Association on the Administrations Proposal to Undermine Funds for Research, Prevention and Treatment in FY09
11. NutraCea Files Universal Shelf Registration Statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: